CAS: 2376577-06-7
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | M2N12 REF: 54-BUP05516CAS: 2376577-06-7 | ≥98% | 704,00 €~1.403,00 € | Mo 12 Mai 25 |
 | M2N12 REF: TM-T11929CAS: 2376577-06-7 | 98.01% | 88,00 €~1.035,00 € | Fr 16 Mai 25 |
 | M2N12 REF: 3D-BVD57706CAS: 2376577-06-7 | Min. 95% | 331,00 €~1.847,00 € | Fr 20 Jun 25 |
Ref: 54-BUP05516
| 25mg | 704,00 € | ||
| 50mg | 1.039,00 € | ||
| 100mg | 1.403,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 12. Mai 2025
M2N12
CAS:2376577-06-7
M2N12 selectively inhibits Cdc25C (IC50=0.09μM) and has anti-tumor properties, affecting Cdc25A and B as well.
Formel:
C20H16ClN5O2
Reinheit:
98.01%
Farbe und Form:
Solid
Molekulargewicht:
393.83
Ref: TM-T11929
| 1mg | 88,00 € | ||
| 5mg | 160,00 € | ||
| 10mg | 250,00 € | ||
| 25mg | 472,00 € | ||
| 50mg | 707,00 € | ||
| 100mg | 1.035,00 € | ||
| 1mL*10mM (DMSO) | 170,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 16. Mai 2025
M2N12
CAS:2376577-06-7
Please enquire for more information about M2N12 including the price, delivery time and more detailed …
Formel:
C20H16ClN5O2
Reinheit:
Min. 95%
Molekulargewicht:
393.8 g/mol
Ref: 3D-BVD57706
| 1mg | 331,00 € | ||
| 5mg | 484,00 € | ||
| 10mg | 690,00 € | ||
| 25mg | 1.155,00 € | ||
| 50mg | 1.847,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 20. Juni 2025
